Oxymatrine protects against DSS-induced colitis via inhibiting the PI3K/AKT signaling pathway.
Chen Q, Duan X, Fan H, Xu M, Tang Q, Zhang L, Shou Z, Liu X, Zuo D, Yang J, Deng S, Dong Y, Wu H, Liu Y, Nan Z.
Chen Q, et al.
Int Immunopharmacol. 2017 Dec;53:149-157. doi: 10.1016/j.intimp.2017.10.025.
Int Immunopharmacol. 2017.
PMID: 29107215